Feel Therapeutics is a Digital Precision Medicine company that aims to revolutionize the diagnosis, management, and care for Mental Health. They strive to eliminate suffering from anxiety and depression through the development of digital biomarkers and therapeutics for personalized interventions. Unlike traditional approaches that rely on self-reported questionnaires and subjective measures, Feel Therapeutics brings objective data and passive measurement into the field of Mental Health.

The company has conducted numerous studies, published patents, and collaborated with Pharma and Biotech partners to advance clinical development and commercialization strategies. Their team of data scientists, engineers, clinicians, researchers, and therapists is fully committed to developing novel digital biomarkers and bringing digital health solutions to market. Headquartered in San Francisco, Feel Therapeutics is backed by top-tier investors.

Their offerings include the Digital Precision Medicine Platform, Precision Digital Therapeutics, and Precision Digital Drug+. Feel Therapeutics is dedicated to transforming the way Mental Health is diagnosed and treated, providing a more accurate and timely intervention for individuals